Estudio de incidencia de trisomía 21 en Gran Canaria

Nicolaides, 2003, Screening for chromosomal defects, Ultrasound Obstet Gynecol, 21, 313, 10.1002/uog.128 Caughey, 2002, Nuchal translucency and first trimester biochemical markers for Down syndrome screening:a cost-effectiveness analysis, Am J Obstet Gynecol, 187, 1239, 10.1067/mob.2002.127144 Cusick, 2003, Combined first-trimester versus second-trimester serum screening for Down syndrome:a cost analysis, Am J Obstet Gynecol, 188, 745, 10.1067/mob.2003.127 Crobman, 2002, Preference assesment of prenatal diagnosis for Down syndrome:is 35 years a rational cutoff?, Prenat Diagn, 22, 1195, 10.1002/pd.494 1999 Chodirker, 2001, Genetic Indications for Prenatal Diagnosis.Canadian Guidelines for Prenatal Diagnosis, J Soc Obstet Gynaecol Can, 23, 525 Bunduki, 2003, Fetal nasal bone lenght:reference range and clinical application in ultrasound screening for trisomy 21, Ultrasound Obstet Gynecol, 21, 156, 10.1002/uog.31 2003, Técnicas invasivas. Protocolos Asistenciales en Obstetricia de la SEGO. N.° 5 Lim, 2002, Nuchal index:a gestational age independent ultrasound marker for the detection of Down syndrome, Prenat Diagn, 22, 1233, 10.1002/pd.497